[Minimal residual disease in leukemia and lymphoma: biological significance and clinical applications].
Gavosto
F
F
Saglìo
G
G
Foà
R
R
D000970:Antineoplastic Agents / Q000494:pharmacology / Q000627:therapeutic use; D014408:Biomarkers, Tumor / Q000032:analysis; D016026:Bone Marrow Transplantation; D003131:Combined Modality Therapy; D004351:Drug Resistance; D006801:Humans; D007938:Leukemia / Q000188:drug therapy / Q000473:pathology* / Q000601:surgery; D008223:Lymphoma / Q000188:drug therapy / Q000473:pathology* / Q000601:surgery
D000970:Antineoplastic Agents; D014408:Biomarkers, Tumor
La malattia minima residua nelle leucemie e nei linfomi: significato biologico e applicazioni cliniche.